Clinical Trial
doi: 10.1016/S0140-6736(99)02153-4.
Serum homocysteine increases after therapy with fenofibrate or bezafibrate
- PMID: 10421307
- DOI: 10.1016/S0140-6736(99)02153-4
Item in Clipboard
Clinical Trial
Serum homocysteine increases after therapy with fenofibrate or bezafibrate
Lancet.
.
Abstract
A 44% and 17.5% increase of homocysteine occurred in patients treated either with fenofibrate or bezafibrate. The increase was not explained by changes in vitamin concentrations but may be related to renal function.
Comment in
-
Implication of fibrate therapy for homocysteine.Lancet. 1999 Oct 2;354(9185):1208. doi: 10.1016/s0140-6736(05)75415-5. Lancet. 1999. PMID: 10513736 Clinical Trial. No abstract available.
-
Implication of fibrate therapy for homocysteine.Lancet. 1999 Oct 2;354(9185):1208-9. doi: 10.1016/S0140-6736(05)75416-7. Lancet. 1999. PMID: 10513737 No abstract available.
-
Implication of fibrate therapy for homocysteine.Lancet. 1999 Oct 2;354(9185):1209. doi: 10.1016/S0140-6736(05)75417-9. Lancet. 1999. PMID: 10513738 No abstract available.
-
Homocysteine and heart disease in Indian Asians.Lancet. 2000 Jun 24;355(9222):2249-50. doi: 10.1016/S0140-6736(05)72745-8. Lancet. 2000. PMID: 10881914 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
